330 likes | 500 Views
M P C Vision 2014 onwards. M P C Vision 2014 onwards. M P C corporate identity ? We cherish life, Born and Unborn ……. 2005– Foundation in November 2005 2006- Business operation February 2006 2007- Joint venture Al-Fath Holding (Yemen)
E N D
MPCVision 2014onwards • MPCcorporate identity ? We cherish life, Born and Unborn……
2005–Foundation in November 2005 2006-Business operation February 2006 2007-Joint venture Al-Fath Holding (Yemen) Menarini, ICN, Solco, Merz, OM Pharma , Phoenix , Elea 2011-New corporate Identity 2013-2014 -3600 new implementation strategy starting November (Route 2020) MPC History
2006 – 2010: Alter Farmacia (Spain) FrieslandCampina (Holland) BBT-Biotech,Ardeypharm,Rhein-Min(Germany) Octapharma (Switzerland) 2010-2011: Green Cross (Korea*) KoreaVaccine (Korea) MPC History
2011-2013: ACRAF-Angelini (Italy) MENA region Agent ABC (Italy) MENA Aciclovir Sigma-Tau (Italy) ME/Levant Agent Richet MENA(Argentina) MENA Richmond (Argentina) SSI (Denmark) MPCStrategiccooperation
2013-2014: Fresenius KabiPvt ltd (India) Bharat Biotech (India) Catalent (Italy) Vinsbioproduct limited(India) Elea(Argentina) LKM (Argentina) GruppoUriach (Spain) MENA LIGA (Kraft Mondelez) MENA* MPCStrategic coperation
MPCOrganizational Structure GM Board of Management President Purchase Manager Regulatory Affairs (2) HR Manager Finance Manager Planning & Marketing support Manager Pediatric Line Accounting Department (3) OB-GYN Line Invoicing Department (2) Vaccine Line Treasury/Financial Analyst
MPCOrganizational Structure 1 Sales Analyst Planning & Marketing support Manager Sales Manager Pediatric Health Supervisor OB- GYN Key account Vaccines (2) Product Specialist Nish market (Octapharma) 8 PSR 4 PSR 2 team coordinator
MPCOrganizational Structure HR Manager Pharmacy Sales Supervisor Sales executive Ambulatories Warehouse controller 5 Sales Consultants Sales executive Vaccine 3 assistants 3 distribution Total MPC employees 54 people
MPCVision 2014onwards • MPC promotes the highest added value for infants nutrition and medical specialties areas through its suppliers know-how by continues development and introduction of high quality products to achieve customers satisfaction……
MPCVision 2014onwards CUSTOMER SATISFACTION Delivery performance Quality Flexibility Cost
MPCVision 2014onwards Consumers & customers expect MPC to deliver high QUALITY products QUALITY delivered throughout trusted reputable suppliers
MPCVision 2014onwards # of Reputable trusted suppliers
MPCVision 2014onwards Quality supply chain • Quality at MPC • - Importers order member 2013 • 3000m2 strategic new location • Triple MPCauditing from 2014 • GPS tracking delivery started Q4 2013 • Electronic PO via ST within Q1 2014 • Quick & full territory delivery chain • ISO accreditation time line by end 2016 • Continues Market analysis…
IMS AC Nielsen Own market survey 1.IMS Market analyses 2.Own market survey 3.Ac Nielsen MPCVision 2014onwards MPCmarket data base
MPCVision 2014onwards MPCexpertise in infant Nutrition • MPC has the largest experience and expertise in the area of infant nutrition and medical specialties: • Dedicated specialized team • Codex alimentarius principals respected • New quality product portfolio • “Only in Pharmacies policy”
MPCFriso Performance Friso the Unique Infant Formula with ProtectionLid……
MPCNutriben Performance Nutriben the Only Instant Naturally Pre-digested baby Cereals GMO-FRE(GREEN PEACE) , with Olive oil…..
MPCLIGA opportunity LIGA The oldest & Only World wide Baby biscuit allergen free…….
MPCOB-GYN Challenge opportunities MPCOB-GYN portfolio Originators only • MPCstrongly believes differentiating it’s OB-GYN team being best achieverteam amongMPCteams during 2014
MPCOctapharma Performance MPCOctapharmaPredominating in Blood derivatives • OctapharmaTHEWORLD’S LARGEST PRIVATELY OWNED PLASMA PRODUCT MANUFACTURER
MPCOctapharma Performance Upcoming opportunities • MPCcommits it’s Key account team specialist continues impressive differentiation…….
MPCSurfactant B Richet Performance MPCsteady growth in RDS, finalizing CNSS listing within Q2 2014 15% 80%
MPCOncologyChallenge opportunities Top 3 Argentinian market leader in Oncology line Top 2 Spanish market leader in Oncology line • MPCgreat opportunity building up unique platform in Oncology line therapy
MPCmarket leaders Challenge opportunities #1 worldwide market leader in hospital line #1 Spanish market leader in OTC line #1 Italian market leader in Rare disease • MPChas the great opportunity growing up together
MPCFacts & Figures # of Suppliers Location score Space in m2 160m2 3 0.5/5 35 3000m2 4.5/5 • MPCas unique hybrid local company aims to be beyond your expectations……………….
MPCFacts & Figures Lines of Business # of Vehicles # of Employees • MPCas unique hybrid local company aims to be beyond your expectations……………….
MPCFacts & Figures • MPCas unique hybrid local company aims to be beyond your expectations……………….
MPCFacts & Figures Business growth 12 SKU 87 SKU • MPCas unique hybrid local company aims to be beyond your expectations……………….
MPCFacts & Figures # of registered products 25 40 • MPCas unique hybrid local company aims to be beyond your expectations……………….
MPCFacts & Figures Investment value 400 K 3000 K • MPCas unique hybrid local company aims to be beyond your expectations……………….